/Unitedhealth%20Group%20Inc%20%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
With UnitedHealth Group gearing up to release its Q2 earnings results this month, analysts project a high single-digit profit surge on the horizon.
/Idexx%20Laboratories%2C%20Inc_%20outside%20lab-by%20Sundry%20Photography%20via%20iStock.jpg)
IDXX Laboratories has recently underperformed the Healthcare sector, but Wall Street analysts are moderately optimistic about the stock’s prospects.
/Humana%20Inc_%20logo%20on%20laptop-by%20monticello%20via%20Shutterstock.jpg)
Humana has recently outperformed the Healthcare sector, and Wall Street analysts are moderately optimistic about the stock’s prospects.
/Cencora%20Inc_%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Shares of Cencora have outperformed the broader healthcare sector over the past year, and Wall Street analysts are bullish about the stock’s prospects.
/Agilent%20Technologies%20Inc_%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Agilent Technologies has lagged the healthcare sector over the past three months, but analysts are optimistic about the stock’s prospects.
/IQVIA%20Holdings%20Inc%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
IQVIA Holdings has underperformed other healthcare stocks over the past three months, but analysts are optimistic about the stock’s prospects.
You can build solid wealth with broad index funds -- or you might try to juice your returns with some superperformers.
/Edwards%20Lifesciences%20Corp%20Irvine%2C%20Ca%20campus-by%20Steve%20Cukrov%20via%20Shutterstock.jpg)
Edwards Lifesciences has recently underperformed the Healthcare sector, but Wall Street analysts anticipate a modest upside for the stock.
/Mckesson%20Corporation%20logo%20on%20building-by%20JHVEPhoto%20via%20iStock.jpg)
McKesson has outperformed other healthcare stocks over the past three months, and analysts remain optimistic about the stock’s prospects.
/Medtronic%20Plc%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Despite Medtronic consistently underperforming the broader healthcare sector, Wall Street analysts remain cautiously optimistic about the stock’s outlook.